Retinopathy in Parkinson disease

Journal of Neural Transmission

Volumn 116, Issue 11, 2009, Pages 1493-1501

  Bodis Wollner, Ivan ^a  

^a SUNY Downstate Medical Center   (United States)

Author keywords

Dopamine receptors; ERG; Foveal vision; Optical coherence tomography; Parkinson disease; Presynaptic cross inhibitory model; Retina; Retinal thinning

Indexed keywords

LEVODOPA; NEUROLEPTIC AGENT;

ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; DISEASE COURSE; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; NERVE CELL; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PARKINSON DISEASE; PRIORITY JOURNAL; RETINA GANGLION CELL; RETINOPATHY; VISION TEST;

ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE; EARLY DIAGNOSIS; FOVEA CENTRALIS; HAPLORHINI; HUMANS; PARKINSON DISEASE; RECEPTORS, DOPAMINE; RETINAL DEGENERATION; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 70449530531     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-009-0292-z     Document Type: Article

References (63)

1. O Altintas P Iseri B Ozkan Y Caglar 2008 Correlation between retinal morphological and functional findings and clinical severity in Parkinsons disease Doc Ophthalmol 1116 137 146 10.1007/s10633-007-9091-8 (Pubitemid 351279805)
2. A Antal R Pfeiffer I Bodis-Wollner 1996 Simultaneously evoked primary and cognitive visual evoked potentials distinguish younger and older patients with Parkinson's disease J Neural Trans 103 1053 1067 10.1007/BF01291790 1:STN:280:DyaK2s7msFKgsA%3D%3D (Pubitemid 26383835)
3. F Berisha GT Feke CL Trempe, et al. 2007 Retinal abnormalities in early Alzheimer's disease Invest Ophthalmol Vis Sci 48 2285 2289 10.1167/iovs.06-1029 17460292 (Pubitemid 351261307)
4. J Birch RU Kolle M Kunkel W Paulus P Upadhyay 1998 Acquired colour deficiency in patients with Parkinson's disease Vision Res 38 3421 3426 10.1016/S0042-6989(97)00398-2 1:STN:280:DyaK1M7gvFymtQ%3D%3D 9893859 (Pubitemid 28416444)
5. EZ Blumenthal JM Williams RN Weinreb, et al. 2000 Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography Ophthalmology 107 2278 2282 10.1016/S0161-6420(00)00341-9 1:STN:280: DC%2BD3M%2FmsF2iug%3D%3D 11097610
6. P Bobak I Bodis-Wollner C Harnois, et al. 1983 Pattern electroretinograms and visual-evoked potentials in glaucoma and multiple sclerosis Am J Ophthalmol 96 72 83 1:STN:280:DyaL3s3ltlehsg%3D%3D 6869481
7. I Bodis-Wollner 1972 Visual acuity and contrast sensitivity in patients with cerebral lesions Science 178 769 771 10.1126/science.178.4062.769 1:STN:280:DyaE3s%2FjtFamtw%3D%3D 5082844
8. I Bodis-Wollner 1990 Visual deficit related to dopamine deficiency in experimental animals and Parkinson's disease Trends Neurosci 13 296 301 10.1016/0166-2236(90)90113-O 1:CAS:528:DyaK3MXktVSqsA%3D%3D 1695407
9. I Bodis-Wollner 2008 Diagnosing and treating early: is there a pre-cardinal stage of Parkinson disease? Parkinson Rep 19 9 10
10. I Bodis-Wollner S Diamond 1976 The measurement of spatial contrast sensitivity in cases of blurred vision associated with cerebral lesions Brain 99 695 710 10.1093/brain/99.4.695 1:STN:280:DyaE2s7lvFeluw%3D%3D 1030654
11. I Bodis-Wollner A Tzelepi 1998 The push-pull action of dopamine on spatial tuning of the monkey retina: the effects of dopaminergic deficiency and selective D1 and D2 receptor ligands on the pattern electroretinogram Vision Res 38 1479 1487 10.1016/S0042-6989(98)00028-5 1:CAS:528:DyaK1cXjs12nsbY%3D 9667012 (Pubitemid 28240968)
12. Bodis-Wollner I, Tzelepi A (2002) Push-pull model of Dopamine's action in the retina in: models of the visual system. Hung GK, Ciuffreda KJ (eds) Kluwer Academic/Plenum Publishers, New York, Boston, Dordrecht, London, Moscow. Chapter 5, pp 191-214
13. Bodis-Wollner I, Tzelepi A (2005) The effect of diverse dopamine receptors on spatial processing in the central retina: a model. Chapter 17. In: Jenkin M, Harris L (eds) Seeing spatial form. Oxford University Press, New York, NY
14. I Bodis-Wollner MD Yahr 1978 Measurement of visual evoked potentials in Parkinson's disease Brain 101 661 671 10.1093/brain/101.4.661 1:STN:280:DyaE1M7gsVyhsw%3D%3D 737524
15. I Bodis-Wollner MS Marx S Mitra, et al. 1987 Visual dysfunction in Parkinsons disease Brain 110 1675 1698 10.1093/brain/110.6.1675 3427405
16. I Bodis-Wollner JR Brannan RL Storch M Hajee M Minko 2009 The effect of background spatial contrast on electroretinographic responses in the human retina Vision Res 49 9 922 930 10.1016/j.visres.2008.07.008 18723047
17. I Bodis-Wollner MD Yahr LH Mylin J Thornton 1982 Dopaminergic deficiency and delayed visual evoked potentials in humans Ann Neurol 11 478 483 10.1002/ana.410110507 1:STN:280:DyaL383lsFajuw%3D%3D 6125124
18. H Braak K Del Tredici H Bratzke, et al. 2002 Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages) J Neurol 249 1 5 10.1007/s00415-002-1301-4
19. C Bulens JD Meerwaldt GJ van der Wildt CJ Keemink 1986 Contrast sensitivity in Parkinson's disease Neurology 36 1121 1125 1:STN:280: DyaL283osFCkuw%3D%3D 3736881
20. T Buttner W Kuhn T Muller T Heinze C Puhl H Przuntek 1996 Chromatic and achromatic visual evoked potentials in Parkinson's disease Electroencephalogr Clin Neurophysiol 100 443 447 1:STN:280:DyaK2s%2FkvV2gsA%3D%3D 8893662
21. DM Dacey 1988 Dopamine-accumulating retinal neurons revealed by in vitro fluorescence display a unique morphology Science 240 4856 1196 1198 10.1126/science.3375811 1:CAS:528:DyaL1cXksVyqs7c%3D 3375811
22. CM Davenport PB Detwiler DM Dacey 2007 Functional polarity of dendrites and axons of primate A1 amacrine cells Vis Neurosci 24 449 457 10.1017/S0952523807070010 17550636 (Pubitemid 47509563)
23. MB Djamgoz MW Hankins J Hirano, et al. 1997 Neurobiology of retinal dopamine in relation to degenerative states of the tissue Vision Res 37 3509 3529 10.1016/S0042-6989(97)00129-6 1:CAS:528:DyaK2sXnslajsLc%3D 9425527 (Pubitemid 27491631)
24. C Enroth-Cugell JG Robson 1966 The contrast sensitivity of retinal ganglion cells of the cat J Physiol 187 3 517 552 1:STN:280: DC%2BD28zmvV2jtw%3D%3D 16783910
25. JM Frederick ME Rayborn AM Laties DM Lam JG Hollyfield 1982 Dopaminergic neurons in the human retina J Comp Neurol 210 1 65 79 10.1002/cne.902100108 1:STN:280:DyaL3s%2FjtFCjsg%3D%3D 6127354
26. MF Ghilardi I Bodis-Wollner MC Onofrj, et al. 1988 Spatial frequency dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model Brain 3 131 184 10.1093/brain/111.1. 131
27. MF Ghilardi MS Marx I Bodis-Wollner, et al. 1989 The effect of intraocular 6-hydroxydopamine on retinal processing of primates Ann Neurol 25 357 364 10.1002/ana.410250407 1:CAS:528:DyaL1MXktVahtLo%3D 2496639 (Pubitemid 19104167)
28. M Hajee W March D Lazzaro A Wolintz E Shrier S Glazman I Bodis-Wollner 2009 Inner retinal layer thinning in Parkinson disease Arch Ophthalmol 127 6 737 741 10.1001/archophthalmol.2009.106 19506190
29. EC Hampson DI Vaney R Weiler 1992 Dopaminergic modulation of gap junction permeability between amacrine cells in mammalian retina J Neurosci 12 4911 4922 1:CAS:528:DyaK3sXhtFOhsb4%3D 1281499
30. C Harnois T DiPaolo 1990 Decreased dopamine in the retinas of patients with Parkinsons disease Invest Ophthalmol Vis Sci 31 2473 2475 1:STN:280:DyaK3M%2FlsF2mtQ%3D%3D 2243012
31. H Hollander S Bisti L Maffei R Hebel 1984 Electroretinographic responses and anterograde changes of morphology after intercranial optic nerve section. A quantitative analysis in the cat Exp Brain Res 5 483 493
32. JT Hutton JL Morris JW Elias 1993 Levodopa improves spatial contrast sensitivity in Parkinson's disease Arch Neurol 50 721 724 1:STN:280: DyaK3szht1ahtQ%3D%3D 8323475
33. H Ikeda GM Head CJ Ellis 1994 Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study Vision Res 34 2629 2638 10.1016/0042-6989(94)90248-8 1:STN:280: DyaK2M%2FmsFOnuw%3D%3D 7975301 (Pubitemid 24256856)
34. R Inzelberg JA Ramirez P Nisipeanu, et al. 2004 Retinal nerve fiber layer thinning in Parkinson disease Vision Res 44 2793 2797 10.1016/j.visres.2004.06. 009 15342223 (Pubitemid 39165558)
35. D Krizaj R Gábriel WG Owen P Witkovsky 1988 Dopamine D2 receptor-mediated modulation of rod-cone coupling in the Xenopus retina J Comp Neurol 398 4 529 538 10.1002/(SICI)1096-9861(19980907)398:4<529::AID- CNE5>3.0.CO;2-4
36. SW Kuffler 1953 Discharge patterns and functional organization of mammalian retina J Neurophysiol 1 37 68
37. L Maffei A Fiorentini S Bisti H Hollander 1985 Pattern ERG in the monkey after section of the optic nerve Exp Brain Res 59 423 425 10.1007/BF00230925 1:STN:280:DyaL2M3osFCnug%3D%3D 4029317
38. M Marx I Bodis-Wollner P Bobak C Harnois 1986 Temporal frequency-dependent VEP changes in Parkinson's disease Vision Res 26 185 193 10.1016/0042-6989(86)90080-5 1:STN:280:DyaL283jslWhtA%3D%3D 3716211 (Pubitemid 16154406)
39. G Masson D Mestre O Blin 1993 Dopaminergic modulation of visual sensitivity in man Fundam Clin Pharmacol 7 8 449 463 10.1111/j.1472-8206.1993. tb01041.x 1:STN:280:DyaK2c7isVSqsQ%3D%3D 8294083
40. J Nguyen-Legros 1988 Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease Surg Radiol Anat 10 2 137 144 10.1007/BF02307822 1:STN:280: DyaL1c3ptV2ntQ%3D%3D 3135618
41. J Nguyen-Legros A Simon I Caillé B Bloch 1997 Immunocytochemical localization of dopamine D1 receptors in the retina of mammals Vis Neurosci 14 3 545 551 10.1017/S0952523800012207 1:STN:280:DyaK2szjslGrsw%3D%3D 9194321
42. J Nguyen-Legros C Versaux-Botteri P Vernier 1999 Dopamine receptor localization in the mammalian retina Mol Neurobiol 19 3 181 204 10.1007/BF02821713 1:CAS:528:DyaK1MXmtlWls7c%3D 10495103
43. M Onofrj I Bodis-Wollner 1982 Dopaminergic deficiency causes delayed VEPs in rats Ann Neurol 11 484 490 10.1002/ana.410110508 1:CAS:528: DyaL38XktFOqtL8%3D 7103424
44. M Onofrj MF Ghilardi M Basciani D Gambi 1986 Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dep endent dopamine function in humans J Neurol Neurosurg Psychiatry 49 10 1150 1159 10.1136/jnnp.49.10.1150 1:STN:280:DyaL2s%2FlvFyqug%3D%3D 3023551
45. A Peppe A Antal M Tagliati P Stanzione I Bodis-Wollner 1998 Dl agonist CY208-243 attenuates the PERG to low spatial frequency stimuli in the monkey Neurosci Lett 242 1 4 10.1016/S0304-3940(98)00009-3 (Pubitemid 28122694)
46. A Peppe P Stanzione M Pierantozzi R Semprini A Bassi AM Santilli R Formisano M Piccolino G Bernardi 1998 Does pattern electroretinogram spatial tuning alteration in Parkinson's disease depend on motor disturbances or retinal dopaminergic loss? Electroencephalogr Clin Neurophysiol 106 4 374 382 10.1016/S0013-4694(97)00075-8 1:STN:280:DyaK1cvht1OqtQ%3D%3D 9741766 (Pubitemid 28198092)
47. M Price R Feldman D Adelberg H Kayne 1992 Abnormalities in color vision and contrast sensitivity in Parkinson's disease Neurology 42 887 890 1:STN:280:DyaK383ivVWrug%3D%3D 1565248
48. D Regan C Maxner 1987 Orientation-selective visual loss in patients with Parkinson's disease Brain 110 Pt 2 415 432 10.1093/brain/110.2.415 3567530
49. D Regan D Neima 1984 Low-contrast letter charts in early diabetic retinopathy, ocular hypertension, glaucoma, and Parkinson's disease Br J Ophthalmol 68 12 885 889 10.1136/bjo.68.12.885 1:STN:280:DyaL2M%2Fnt1OltQ%3D%3D 6509009
50. F Sartucci G Orlandi C Lucetti, et al. 2003 Changes in pattern electroretinograms to equiluminant red-green and blue-yellow gratings in patients with early Parkinson's disease J Clin Neurophysiol 20 375 381 10.1097/00004691-200309000-00010 14701999 (Pubitemid 38031212)
51. JS Schulman T Pedut-Kloizman E Hertzmark, et al. 1996 Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography Ophthalmology 103 1889 1898 (Pubitemid 26403745)
52. MF Silva P Faria FS Regateiro V Forjaz C Januário A Freire M Castelo-Branco 2005 Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease Brain 128 2260 2271 10.1093/brain/awh581 1:STN:280:DC%2BD2MrgvFOjtQ%3D%3D 16000338 (Pubitemid 41407966)
53. LR Skirboll AA Grace BS Bunney 1977 Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists Science 206 80 82 10.1126/science.482929
54. P Stanzione M Pierantozzi R Semprini M Tagliati R Traversa A Peppe, et al. 1995 Increasing doses of l-sulpiride reveal dose- and spatial frequency-dependent effects of D2 selective blockade in the human electroretinogram Vision Res 35 2659 2664 10.1016/0042-6989(95)00037-Z 1:CAS:528:DyaK2MXos1Chsrc%3D 7483307
55. M Tagliati I Bodis-Wollner MD Yahr 1996 The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning Electroencephalogr Clin Neurophysiol 100 1 11 10.1016/0168-5597(95)00169-7 1:STN:280: DyaK283gt1KntQ%3D%3D 8964257 (Pubitemid 26068247)
56. M Tagliati I Bodis-Wollner I Kovanecz P Stanzione 1994 Spatial frequency tuning of the monkey pattern ERG depends on D2 receptor-linked action of dopamine Vision Res 34 2051 2057 10.1016/0042-6989(94)90316-6 1:CAS:528:DyaK2cXlt1Gru78%3D 7941404 (Pubitemid 24191657)
57. A Tartaglione N Pizio G Bino L Spadavecchia E Favale 1984 VEP changes in Parkinson's disease are stimulus dependent J Neurol Neurosurg Psychiatry 47 3 305 307 10.1136/jnnp.47.3.305 1:STN:280:DyaL2c7mtl2ksw%3D%3D 6707679
58. A Tartaglione A Oneto F Bandini E Favale 1987 Visual evoked potentials and pattern electroretinograms in Parkinson's disease and control subjects J Neurol Neurosurg Psychiatry 50 9 1243 1244 10.1136/jnnp.50.9.1243 1:STN:280:DyaL1c%2FjsFSqsw%3D%3D 3668582
59. DA Valenti 2007 Neuroimaging of retinal nerve fiber layer in AD using optical coherence tomography Neurology 69 1060 10.1212/01.wnl.0000280584.64363. 83 17785676 (Pubitemid 47366061)
60. P Witkovsky 2004 Dopamine and retinal function Doc Ophthalmol 108 17 39 10.1023/B:DOOP.0000019487.88486.0a 15104164 (Pubitemid 38461014)
61. P Witkovsky R Gabriel D Krizaj A Akopian 1995 Feedback from luminosity horizontal cells mediates depolarizing responses of chromaticity horizontal cells in the Xenopus retina Proc Natl Acad Sci USA 92 8 3556 3560 10.1073/pnas.92.8.3556 1:CAS:528:DyaK2MXltFSmsLo%3D 7724597
62. M Wojtkowski V Srinivasan J Fujimoto, et al. 2005 Three-dimensional retinal imaging with high speed ultrahigh resolution optical coherence tomography Ophthalmology 112 1734 1746 10.1016/j.ophtha.2005.05.023 16140383 (Pubitemid 41400010)
63. GF Yavas O Yilmaz T Küsbeci F Oztürk 2007 The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease Eur J Ophthalmol 17 812 816 1:STN:280:DC%2BD2sngvVGgsQ%3D%3D 17932860